Valuation: Medpace Holdings, Inc.

Market Cap 17.09B 14.9B 14.04B 12.78B 23.96B 1,637B 23.99B 168B 64.78B 834B 64.2B 62.78B 2,692B P/E 2026 *
34.8x
P/E 2027 * 32x
Enterprise Value 16.29B 14.2B 13.38B 12.18B 22.84B 1,561B 22.87B 160B 61.74B 795B 61.19B 59.83B 2,565B EV / Sales 2026 *
5.71x
EV / Sales 2027 * 5.23x
Free-Float
80.34%
Yield 2026 *
-
Yield 2027 * -
1 day+1.94%
1 week+4.84%
Current month+5.09%
1 month+0.56%
3 months+36.99%
6 months+36.61%
Current year+11.14%
1 week 594.08
Extreme 594.08
627.04
1 month 577.64
Extreme 577.64
627.04
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
16/09/26 Sell

Chief Executive Officer

-8,770 0.0314%
15/09/26 Exercice

Chief Operating Officer

6,000 0.0215%
27/08/26 Sell

Chief Executive Officer

-650 0.0023%
Change 5-day change 1-year change 3-year change Capi.($)
+1.94%+4.84%+25.32%+159.21% 17.09B
+0.59%+3.31%+1.03%+24.53% 46.28B
+1.30%+1.58%+43.68%+35.50% 43.85B
+0.95%-6.02%+334.05%+532.41% 40.93B
+4.23%+3.35%+8.25%+94.73% 39.89B
+1.11%+1.80%+11.52%+43.15% 29.5B
+0.37%-10.32% - - 15.55B
+2.12%+10.41%+24.78%+39.05% 15.22B
+0.24%+25.43%-9.13% - 14.05B
+0.34%+2.16%+81.30%+40.81% 13.27B
Average +1.36%+3.57%+57.87%+121.17% 27.56B
Weighted average by Cap. +1.54%+1.98%+69.46%+135.72%

Financials

2026 *2027 *
Net sales 2.85B 2.49B 2.34B 2.13B 4B 273B 4B 28.05B 10.81B 139B 10.71B 10.47B 449B 3.03B 2.64B 2.49B 2.26B 4.24B 290B 4.25B 29.77B 11.47B 148B 11.37B 11.12B 477B
Net income 503M 438M 413M 376M 705M 48.15B 706M 4.94B 1.9B 24.53B 1.89B 1.85B 79.14B 547M 477M 449M 409M 766M 52.36B 767M 5.38B 2.07B 26.67B 2.05B 2.01B 86.08B
Net Debt -802M -700M -659M -600M -1.12B -76.86B -1.13B -7.89B -3.04B -39.15B -3.01B -2.95B -126B -1.25B -1.09B -1.03B -936M -1.76B -120B -1.76B -12.31B -4.75B -61.11B -4.7B -4.6B -197B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
22/09/26 $624.20 +1.94% 184,241
18/09/26 $612.33 -0.46% 522,196
17/09/26 $615.18 -0.20% 226,115
16/09/26 $616.44 -0.65% 208,149
15/09/26 $620.48 +4.21% 303,860
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
612.33USD
Average target price
581.83USD
Spread / Average Target
-4.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!